Vous avez cherché: persistuojancia (Lituanien - Anglais)

lengva persistuojancia astma sergantiems pacientams negali bti svarstomas kombinuotos imt taikymas, o sunkesne ligos forma sergantiems pacientams gali bti taikomas intensyvesnis gydymas.
patients with mild persistent asthma are not considered to be candidates for a combination therapy as imt and patients with a more severe disease would deserve more intensive therapeutic approaches.

4. 2 skyriuje pateikta rekomendacija leidzia trump laik skirti seretide discus vidutinio sunkumo persistuojancia astma sergantiems suaugusiesiems ir paaugliams, kuriems btina skubi astmos kontrol.
the recommendation included in section 4.2 allows a short term trial of seretide diskus in adults and adolescents with moderate persistent asthma for whom rapid control of asthma is essential.

terapijos fiksuotomis salmeterolio ir fliutikazono propionato dozmis vidutinio sunkumo persistuojancia astma sergantiems pacientams, nra priimtina, nes tai gali lemti pernelyg intensyv gydym, ypac pacientams, kuriems uztekt vien tik inhaliuojamj kortikosteroid.
combination of salmeterol and fluticasone propionate in patients with moderate persistent asthma in section 4.1 of the spc is not acceptable as it could result in overtreatment particularly in patients who would have responded to inhaled corticosteroids alone.

zmonms skirt vaist komiteto (chmp) svarstomas klausimas buvo toks: ar visiems ltine persistuojancia astma sergantiems pacientams tinka pirmin palaikomoji terapija fiksuotomis salmeterolio ir fliutikazono propionato dozmis.
the issue to be considered by chmp was whether it is appropriate to introduce initial maintenance therapy with the fixed dose combination of salmeterol and fluticasone propionate in all patients with chronic persistent asthma.

registravimo liudijimo turtojai svarbi ir gerai atlikt klinikini tyrim metu parod, kad vidutinio sunkumo ltine persistuojancia astma sergantiems pacientams, kuri liga blogai kontroliuojama vien tik trumpai veikianciais -agonistais, kombinuotas gydymas salmeteroliu ir fliutikazonu yra veiksmingesnis nei gydymas vien tik salmeteroliu ar fliutikazonu.
the mahs have demonstrated in a series of substantial and well conducted clinical studies that in patients with moderate chronic persistent asthma poorly controlled on a short acting -agonist alone the introduction of combination therapy with salmeterol and fluticasone is more effective in improving disease control than the introduction of salmeterol or fluticasone alone.